IRCT20240304061158N6 IRCT 2026-07-07 Behpad Teb Iranian Efficacy of BT DERMA product in the treatment of cutaneous fungal infections Comparison of the Efficacy and Safety of Adding Topical BT DERMA to Standard Therapy versus Standard Therapy Alone in Patients with Dermatophytosis 2026-08-23 anticipated 30 Pending https://irct.ir/trial/89208 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment, Other design features: The study will be conducted using a split-body design. 2-3 Skin fungi (dermatophytes). Intervention 1: Intervention group: Patients will receive oral itraconazole 200 mg once daily plus ketoconazole 2% shampoo (with each bath, at least twice and up to five times weekly). For topical treatment, one lesion on one side of the limb will receive BT DERMA and clotrimazole 1% cream twice daily for at least 4 weeks, continuing until improvement is observed. Intervention 2: Control group: Patients will receive oral itraconazole 200 mg once daily plus ketoconazole 2% shampoo (with each bath, at least twice and up to five times weekly). For topical treatment, one lesion on one side of the limb will receive clotrimazole 1% cream twice daily for at least 4 weeks, continuing until improvement is observed. No - There is not a plan to make this available Justification or reason for not sharing IPD is Ethical consideration about patient information